Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Intravitreal triamcinolone favorable in treating persistent DME
Fort Lauderdale, FL-In the short term, intravitreal triamcinolone acetonide (4 mg) reduces the risk of progressive loss of vision and commonly improves vision in patients with diabetic cystoid foveal edema that persists after laser treatment, said Mark C. Gillies, MD, PhD, at the annual meeting of the Association for Research in Vision and Ophthalmology.
Related Videos
Related Content
